MEDICINES CONTROL COUNCIL

Size: px
Start display at page:

Download "MEDICINES CONTROL COUNCIL"

Transcription

1 MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 06/17.1.6/07 AFRIVET LOGISTICS 08/ /03 CIPLA MEDPRO (PTY) 09/ /19 CEVA ANIMAL HEALTH 10/5.3.2/11 ACCORD HEALTHCARE 10/5.3.2/12 ACCORD HEALTHCARE 10/5.3.2/13 ACCORD HEALTHCARE 10/5.3.2/14 ACCORD HEALTHCARE 37/21.5.1/0013 BIOTECH 37/21.5.1/0014 BIOTECH 37/21.5.1/0015 BIOTECH MARBOCYL 10 % PETCAM INJECTION 0,5 % CANIFLAM BREXACE 5 PETACE 20 BREXACE 20 PETACE 20 PULMAX 100 MDI PULMAX 200 MDI PULMAX 400 MDI MARBOFLOXACIN 100,0 mg MELOXICAM MELOXICAM 1,5 mg BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE 20,0 mg BENAZEPRIL HYDROCHLORIDE 20,0 mg BENAZEPRIL HYDROCHLORIDE Each actuation contains: BUDESONIDE 100,0 µg Each actuation contains: BUDESONIDE 200,0 µg Each actuation contains: BUDESONIDE 400,0 µg 41/11.4.3/0449 BAYER RENNIE DUO Each 10,0 ml contains: CALCIUM CARBONATE 1 200,0 mg MAGNESIUM CARBONATE 140,0 mg SODIUM ALGINATE 300,0 mg 12.76_Notification_of Dec13_v1 April 2014 Page 1 of 10

2 41/5.7.1/0555 GULF DRUG COMPANY 41/20.1.1/586 AUROBINDO PHARMA 41/20.1.1/587 AUROBINDO PHARMA GULF CETIRIZINE 10 LIZORP 250 mg LIZORP 500 mg 42/3.2/0410 LITHA PHARMA ASTERIX ALENDRONATE 70 42/2.7/0543 CIPLA MEDPRO (PTY) PARAFIZZ 500 CETIRIZINE DIHYDROCHLORIDE CEPROZIL MONOHYDRATE equivalent to ANHYDROUS CEFPROZIL 250,0 mg CEPROZIL MONOHYDRATE equivalent to ANHYDROUS CEFPROZIL 500,0 mg ALENDRONATE SODIUM TRIHYDRATE equivalent to ALENDRONIC ACID 70,0 mg PARACETAMOL 500,0 mg 42/26/0742 PHARMAPLAN CANOTEC IRINOTECAN HYDROCHLORIDE TRIHYDRATE 20,0 mg 42/3.2/0767 PHARMA DYNAMICS 42/3.2/0768 PHARMA DYNAMICS 42/20.1.1/0998 PHARMA DYNAMICS 43/5.3/0099 PFIZER LABORATORIES 43/5.3/0100 PFIZER LABORATORIES 43/1.2/0339 LEBASI cc 43/1.2/0340 LEBASI cc 43/26/0467 SAFELINE DYNA RISEDRONATE 5 mg DYNA RISEDRONATE 35 mg LEVONIC IV 500 ARICEPT ODT 5 mg ARICEPT ODT 10 mg DYNA SERTRALINE 50 DYNA SERTRALINE 100 PLIXEL RISEDRONATE SODIUM HEMIPENTAHYDRATE equivalent to RISEDRONATE SODIUM RISEDRONATE SODIUM HEMIPENTAHYDRATE equivalent to RISEDRONATE SODIUM 3 Each 100,0 ml solution contains: LEVOFLOXACIN 500,0 mg HYDROCHLORIDE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE equivalent to SERTRALINE 50,0 mg SERTRALINE HYDROCHLORIDE equivalent to SERTRALINE 100,0 mg PACLITAXEL 30,0 mg 43/5.3/0668 PHARMAPLAN ARIMER 5 mg HYDROCHLORIDE 12.76_Notification_of Dec13_v1 April 2014 Page 2 of 10

3 43/5.3/0669 PHARMAPLAN ARIMER 10mg HYDROCHLORIDE 43/7.5/0837 PHARMACIA SOUTH AFRICA 43/7.5/0839 PHARMACIA SOUTH AFRICA ASPAVOR 80 ATORVASTATIN PHARMACIA 80 ATORVASTATIN CALCIUM TRIHYDRATE equivalent to ATORVASTATIN 80,0 mg ATORVASTATIN CALCIUM TRIHYDRATE equivalent to ATORVASTATIN 80,0 mg 43/7.1.3/0925 BIOGARAN SA FLAMIPAX 5/5 43/7.1.3/0926 BIOGARAN SA FLAMIPAX 5/10 43/7.1.3/0927 BIOGARAN SA FLAMIPAX 10/5 43/7.1.3/0928 BIOGARAN SA FLAMIPAX 10/10 43/7.1.3/0929 BIOGARAN SA REAPTAN 5/5 43/7.1.3/0930 BIOGARAN SA REAPTAN 5/10 43/7.1.3/0931 BIOGARAN SA REAPTAN 10/ _Notification_of Dec13_v1 April 2014 Page 3 of 10

4 43/7.1.3/0932 BIOGARAN SA REAPTAN 10/10 43/7.1.3/0933 SERVIER LABORATORIES SA (PTY) 43/7.1.3/0934 SERVIER LABORATORIES SA (PTY) 43/7.1.3/0935 SERVIER LABORATORIES SA (PTY) 43/7.1.3/0936 SERVIER LABORATORIES SA (PTY) 43/7.1.3/0937 EGIS SA 43/7.1.3/0938 EGIS SA 43/7.1.3/0939 EGIS SA 43/7.1.3/0940 EGIS SA COVERAM 5/5 COVERAM 5/10 COVERAM 10/5 COVERAM 10/10 MIXANVAL 5/5 MIXANVAL 5/10 MIXANVAL 10/5 MIXANVAL 10/ _Notification_of Dec13_v1 April 2014 Page 4 of 10

5 43/20.1/0954 ASTRAZENECA 43/20.1.1/1025 CK INGRAM 44/8.2/0041 SANOFI-AVENTIS SOUTH AFRICA 44/8.2/0042 WINTHROP 44/8.2/0043 SANOFI-AVENTIS SOUTH AFRICA 44/2.5/0065 CK INGRAM 44/2.5/0066 CK INGRAM 44/2.5/0067 CK INGRAM 44/2.5/0068 CK INGRAM 44/2.5/0069 CK INGRAM 44/2.5/0070 CK INGRAM 44/2.5/0120 CK INGRAM 44/2.5/0121 CK INGRAM 44/2.5/0122 CK INGRAM 44/2.5/0123 CK INGRAM 44/2.5/0124 CK INGRAM 44/2.5/0125 CK INGRAM 44/2.5/0126 CK INGRAM 44/2.5/0127 CK INGRAM CUBICIN CIPROFLOXACIN 2 mg/ml CLOPIDOGREL SANOFI-AVENTIS 300 mg CLOPIWIN 300 mg PLAVIX 300 mg PROPAN 300 CR PROPAN 500 CR VANAPRO 300 VANAPRO 500 SODIUM VALPROATE 300 CR SODIUM VALPROATE 500 CR KEPRACET 250 KEPRACET 500 KEPRACET 750 KEPRACET LEVETIRACETAM 250 LEVETIRACETAM 500 LEVETIRACETAM 750 LEVETIRACETAM DAPTOMYCIN 500,0 mg Each 1 ml solution contains: CIPROFLOXACIN 2,0 mg CLOPIDOGREL HYDROGEN SULPHATE equivalent to CLOPIDOGREL 300,0 mg CLOPIDOGREL HYDROGEN SULPHATE equivalent to CLOPIDOGREL 300,0 mg CLOPIDOGREL HYDROGEN SULPHATE equivalent to CLOPIDOGREL 300,0 mg 300,0 mg 500,0 mg 300,0 mg 500,0 mg 300,0 mg 500,0 mg LEVETIRACETAM 250,0 mg LEVETIRACETAM 500,0 mg LEVETIRACETAM 750,0 mg LEVETIRACETAM 1 000,0 mg LEVETIRACETAM 250,0 mg LEVETIRACETAM 500,0 mg LEVETIRACETAM 750,0 mg LEVETIRACETAM 1 000,0 mg 12.76_Notification_of Dec13_v1 April 2014 Page 5 of 10

6 44/11.4.3/0208 ASTRAZENECA 44/11.4.3/0209 ASTRAZENECA NEXIUM 2,5 mg SACHETS NEXIUM 5 mg SACHETS 44/3.2/0258 SANDOS SA SANDOZ IBANDRONATE 2 mg/2 ml 44/3.2/0259 SANDOS SA SANDOZ IBANDRONATE 6 mg/6 ml Each sachet contains: ESOMEPRAZOLE MAGNESIUM TRIHYDRATE equivalent to ESOMEPRAZOLE 2,5 mg Each sachet contains: ESOMEPRAZOLE MAGNESIUM TRIHYDRATE equivalent to ESOMEPRAZOLE Each ampoule contains: IBANDRONATE SODIUM MOHOHYDRATE equivalent to IBANDRONIC ACID 2,0 mg Each ampoule contains: IBANDRONATE SODIUM MOHOHYDRATE equivalent to IBANDRONIC ACID 6,0 mg 44/7.1.3/0265 RANBAXY (SA) CANDESARTAN RAN 8 CANDESARTAN CILEXETIL 8,0 mg 44/7.1.3/0266 RANBAXY (SA) CANDESARTAN RAN 16 CANDESARTAN CILEXETIL 16,0 mg 44/7.1.3/0267 RANBAXY (SA) CANDAGEN 8 CANDESARTAN CILEXETIL 8,0 mg 44/7.1.3/0268 RANBAXY (SA) CANDAGEN 16 CANDESARTAN CILEXETIL 16,0 mg 44/3.2/0319 SANDOZ SA BONATE 2 mg/2 ml Each ampoule contains: IBANDRONATE SODIUM MONOHYDRATE equivalent to IBANDRONIC ACID 2,0 mg 44/3.2/0320 SANDOZ SA BONATE 6 mg/6 ml Each ampoule contains: IBANDRONATE SODIUM MONOHYDRATE equivalent to IBANDRONIC ACID 6,0 mg 44/20.1.1/0421 TRINITY PHARMA (PTY) 44/20.1.1/0422 TRINITY PHARMA (PTY) 44/32.2/0631 ALKEM LABORATORIES LEVOFLOXACIN TRINITY 250 LEVOFLOXACIN TRINITY 500 MYCOKEM 500 LEVOFLOXACIN 250,0 mg LEVOFLOXACIN 500,0 mg MYCOPHENOLATE MOFETIL 500,0 mg 44/21.10/0763 FERRING BRAVELLE 75 I.U. UROFOLLITROPIN 75,0 I.U. 44/21.10/0764 FERRING BRAVELLE SOLVENT Each ampoule contains: SODIUM CHLORIDE (0,9 %) and 1,0 ml WATER FOR INJECTION 44/26/0886 PHARMAPLAN IMALEK 100 IMATINIB MESILATE equivalent to IMATINIB 100,0 mg 12.76_Notification_of Dec13_v1 April 2014 Page 6 of 10

7 44/26/0887 PHARMAPLAN IMALEK 400 IMATINIB MESILATE equivalent to IMATINIB 400,0 mg 44/1.2/0948 AUROBINDO PHARMA 44/1.2/0949 AUROBINDO PHARMA 44/1.2/0950 AUROBINDO PHARMA 44/1.2/0951 AUROBINDO PHARMA 44/1.2/0952 AUROBINDO PHARMA 44/1.2/0953 AUROBINDO PHARMA 44/1.2/0954 AUROBINDO PHARMA 44/1.2/0955 AUROBINDO PHARMA 44/1.2/0956 AUROBINDO PHARMA 44/11.4.3/0981 CK INGRAM 44/11.4.3/0982 CK INGRAM PRATALOPRAM 5 mg PRATALOPRAM 10 mg PRATALOPRAM 20 mg DOLIN 5 mg DOLIN 10 mg DOLIN 20 mg MARPREM 5 mg MARPREM 10 mg MARPREM 20 mg PANTOPRAZOLE IV PANTOPRAZOLE COVAN INJECTION ESCITALPRAM OXALATE 20,0 mg 20,0 mg 20,0 mg Each 15,0 ml solution contains: PANTOPRAZOLE SODIUM SESQUIHYDRATE equivalent to PANTOPRAZOLE 40,0 mg Each 15,0 ml solution contains: PANTOPRAZOLE SODIUM SESQUIHYDRATE equivalent to PANTOPRAZOLE 40,0 mg 44/21.12/1009 PHARMAPLAN ANABREZ 1 ANASTROZOLE 1,0 mg 45/15.1/0034 CK INGRAM FOXIN CIPROFLOXACIN HYDROCHLORIDE equivalent to CIPROFLOXACIN 3,0 mg 12.76_Notification_of Dec13_v1 April 2014 Page 7 of 10

8 45/26/0038 ELI LILLY (SA) LILLY PEMETREXED 100 mg 45/26/0039 ELI LILLY (SA) LILLY PEMETREXED 500 mg PEMETREXED 100,0 mg PEMETREXED 500,0 mg 45/20.1.1/0100 RANBAXY (SA) TARBACT 200 TEICOPLANIN 200,0 mg 45/20.1.1/0101 RANBAXY (SA) TARBACT 400 TEICOPLANIN 400,0 mg 45/20.1.1/0102 RANBAXY (SA) TARBACT SOLVENT Each ampoule contains: WATER FOR INJECTION 3,0 ml 45/26/0184 CIPLA MEDPRO (PTY) 45/26/0185 CIPLA MEDPRO (PTY) 45/32.2/0219 ALKEM LABORATORIES 45/32.2/0220 ALKEM LABORATORIES 45/32.2/0221 ALKEM LABORATORIES 45/8.3/0335 EQUITY BLEOCIP CIPLA BLEOMYCIN MYCOPHENOLATE ALKEM 250 mg MYCOPHENOLATE ALKEM 500 mg MYCOKEM 250 EQUIFER BLEOMYCIN SULPHATE equivalent to BLEOMYCIN 15 units BLEOMYCIN SULPHATE equivalent to BLEOMYCIN 15 units Each capsule contains: MYCOPHENOLATE MOFETIL 250,0 mg Each capsule contains: MYCOPHENOLATE MOFETIL 500,0 mg Each capsule contains: MYCOPHENOLATE MOFETIL 250,0 mg IRON (III)-HYDROXIDE SUCROSE COMPLEX equivalent to IRON 20,0 mg 45/21/12/0425 RANBAXY (SA) EXERAN EXEMESTANE 2 45/21.12/0487 ARROW PHARMA SOUTH AFRICA 45/2.7/0531 FRESENIUS KABI SOUTH AFRICA 45/20.1.1/0554 LITHA PHARMA (PTY) 45/20.1.1/0555 LITHA PHARMA (PTY) 45/20.1.1/0556 LITHA PHARMA (PTY) 45/20.2.8/0588 AUROBINDO PHARMA 45/20.2.8/0589 AUROBINDO PHARMA ANASTROZOLE WATSON PARACETAMOL FRESENIUS 10 mg/ml (50 ml) TEICOPLANIN LITHA 200 TEICOPLANIN LITHA 400 SOLVENT FOR TEICOPLANIN LITHA VALZOST 500 mg VALZOST 1 g ANASTROZOLE 1,0 mg PARACETAMOL TEICOPLANIN 200,0 mg TEICOPLANIN 400,0 mg Each ampoule contains: WATER FOR INJECTION 3,0 ml VALACICLOVIR HCl equivalent to VALACICLOVIR 500,0 mg VALACICLOVIR HCl equivalent to VALACICLOVIR 1,0 g 12.76_Notification_of Dec13_v1 April 2014 Page 8 of 10

9 45/2.5/0711 BIOTECH 45/2.5/0712 BIOTECH 45/2.5/0713 BIOTECH 45/5.3/0939 ZYDUS HEALTHCARE SA 45/5.3/0940 ZYDUS HEALTHCARE SA 45/5.3/0941 ZYDUS HEALTHCARE SA 45/5.3/0942 ZYDUS HEALTHCARE SA 45/2.7/1188 FRESENIUS KABI SOUTH AFRICA LEVETIRACETAM 250 BIOTECH LEVETIRACETAM 750 BIOTECH LEVETIRACETAM BIOTECH ALZIDO 5 mg ALZIDO 10 mg ZYDUS 5 mg ZYDUS 10 mg PARACETAMOL FRESENIUS 10 mg/ml (100 ml) LEVETIRACETAM 250,0 mg LEVETIRACETAM 750,0 mg LEVETIRACETAM 1 000,0 mg HYDROCHLORIDE HYDROCHLORIDE HYDROCHLORIDE HYDROCHLORIDE PARACETAMOL 46/8.2/0111 BAYER XARELTO 15 RIVAROXABAN 1 46/20.1.8/0793 PHARMACARE EDURANT RILPIVIRINE HYDROCHLORIDE equivalent to RILPIVIRINA 2 46/8.3/0849 ACTOR PHARMA (PTY) 47/20.2.8/0327 CK INGRAM RAUTEVENE RIZENE Each ampoule contains: IRON (III)-HYDROCHLORIDE SUCROSE COMPLEX equivalent to IRON 100,0 mg EFAVIRENZ 600,0 mg EMTRICITABINE 200,0 mg TENOFOVIR DISOPROXIL FUMARATE 300,0 mg 47/20.2.8/0740 SPECPHARM TENEMCOM EMTRICITABINE 200,0 mg TENOFOVIR DISOPROXIL FUMARATE 300,0 mg A40/34/0520 A40/34/0523 A40/34/0565 JOHNSON & JOHNSON JOHNSON & JOHNSON JOHNSON & JOHNSON NICORETTE FRESHMINT 2 mg NICORETTE FRESHMINT 4 mg NICORETTE ICE MINT 2 mg Each piece of gum contains: NICORETTE RESINATE 20 % equivalent to NICOTINE 2,0 mg Each piece of gum contains: NICOTINE RESIN equivalent to NICOTINE 4,0 mg Each piece of gum contains: NICOTINE RESIN equivalent to NICOTINE 2,0 mg 12.76_Notification_of Dec13_v1 April 2014 Page 9 of 10

10 A40/34/0566 JOHNSON & JOHNSON NICORETTE ICE MINT 4 mg Each piece of gum contains: NICOTINE RESIN equivalent to NICOTINE 4,0 mg MS M HELA REGISTRAR OF MEDICINES 12.76_Notification_of Dec13_v1 April 2014 Page 10 of 10

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/3.1.2/14 INGELHEIM A39/34/0605

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 47/26/0920 SANOFI-AVENTIS

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/20.1.2/0204 BIOTECH 36/20.1.2/0205

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 41/20.1.1/0039 SCP MYLAN

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/5.1/09 INGELHEIM 08/5.1/10

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/7.5/0281 PHARMACARE LIMITED

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 26 July 2011 No. 4761

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 26 July 2011 No. 4761 GOVERNMENT GAZETTE OF THE REPUBLIC OF N$4.00 WINDHOEK - 26 July 2011 No. 4761 CONTENTS Page GOVERNMENT NOTICE No. 122 Registration of certain medicines: Medicines and Related Substances Control Act, 2003...

More information

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH 1 Abacavir Sulphate Antiretroviral - * - 2 Abiraterone Acetate Oncology - - - 3 Albendazole Anti-infective - - - 4 Albuterol Sulphate Respiratory - - 5 Alendronate Sodium Trihydrate Metabolic Disorder

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 30/2.10/0392 TEVA TEVA BACLOFEN

More information

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$5.60 WINDHOEK - 31 July 2012 No. 5003

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$5.60 WINDHOEK - 31 July 2012 No. 5003 GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA N$5.60 WINDHOEK - 31 July 2012 No. 5003 CONTENTS Page GOVERNMENT NOTICES No. 186 Cancellation of certain medicines: Medicines and Related Substances Control

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration

More information

AVAILABLE DOSSIERS. Product name Pharmaceutical form Strength Reference Therapeutic class

AVAILABLE DOSSIERS. Product name Pharmaceutical form Strength Reference Therapeutic class DOSSIER LIST AVAILABLE DOSSIERS Product name Pharmaceutical form Strength Reference Therapeutic class ALIMENTARY TRACT & METABOLISM Esomeprazole sodium Omeprazole sodium injection / 40 mg Nexium / AstraZeneca

More information

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Product Name Strength Dosage Form Therapeutic Area Dossier Status Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Alendronate Sodium 10/70mg Tablets Osteoporosis Approved Anastrozole

More information

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Product Number API Test product Dose/ mg Manufacturer Country of manufacture Country

More information

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6 Abiraterone Tablet 250 mg Q4 2016 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Available Alendronic Acid Tablet 70 mg Available Amikacin Solution for injection 50 mg/ml; 125mg/ml;

More information

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs Pharmacy Benefact A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS Number 723 February 2018 Pan-Canadian Select Molecule Price Initiative for Generic Drugs Alberta Drug Benefit List prices

More information

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M % June 2016 On 13th May, the DH announced that there would be reductions to Category M prices from June until September. http://psnc.org.uk/our-news/contractor-notice-category-m-price-reduction/ This has

More information

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$2.00 WINDHOEK - 3 June 2011 No. 4726

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$2.00 WINDHOEK - 3 June 2011 No. 4726 GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA N$2.00 WINDHOEK - 3 June 2011 No. 4726 CONTENTS Page GOVERNMENT NOTICE No. 71 Medicines and Related Substances Control Act, 2003: Registration of certain medicines...

More information

DT Description Price Category Price change

DT Description Price Category Price change Tariff T Watch October 2014 Readers are no doubt aware of this quarter's bad news for primary care prescribing allocations: NHS England has d the remuneration mechanism for community pharmacies gaining

More information

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5 Abiraterone Tablet 250 mg Q4 2015 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Q4 2014 Alendronic Acid Tablet 70 mg Available Amisulpride Tablet 50 ; 100 ; 200 ; 400 mg Available

More information

MRP Monthly Update MRP 12/2013

MRP Monthly Update MRP 12/2013 Monthly Update 12/2013 13/12/2013 Mediscor Reference Price - Notification Effective Date: 1 January 2014 Dear Vendors and Colleagues, The files for January 2014 are now available on our website: www.mediscor.net/mrp.html

More information

CONTACT POLPHARMA GROUP POLPHARMA B2B

CONTACT POLPHARMA GROUP POLPHARMA B2B DOSSIER FDFLIST Product name Pharmaceutical form Strength Reference Therapeutic class ALIMENTARY TRACT & METABOLISM 1. Esomeprazole sodium or injection 40 mg Nexium / AstraZeneca Antiulcerant 2. Omeprazole

More information

List of COPP Skybiotech Life sciences Pvt.Ltd. Factory : Gut No.5, Gevrai Tanda, Paithan Road, Aurangabad.

List of COPP Skybiotech Life sciences Pvt.Ltd. Factory : Gut No.5, Gevrai Tanda, Paithan Road, Aurangabad. List of COPP Skybiotech Life sciences Pvt.Ltd. Factory : Gut No.5, Gevrai Tanda, Paithan Road, Aurangabad. S.NO NAME OF PRODUCT COMPOSITION 01 DOLAFREE -50 Tramadol Hydrochloride Tablet 50 mg ( Sublingual

More information

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M. April 2018 The usual quarterly of Category M prices Another set of similar comments as I made in January: significant increases in many lines which have been subject to price concessions but even more

More information

Innovative Products Available. OTC Products Available

Innovative Products Available. OTC Products Available Innovative Products Benfotiamine film-coated tablets 150 mg Cholecalciferol film-coated tablets 22400 I.U. Diltiazem rectal ointment 2% Agents for Treatment of Hemorrhoids and Fissures Blood and Blood

More information

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M %

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M % December 16 No Category M changes so the reductions imposed in May which were only supposed to last until September continue As in November, most changes are Category A lines with a few Category C. Significant

More information

Alaska Medicaid 90 Day** Generic Prescription Medication List

Alaska Medicaid 90 Day** Generic Prescription Medication List 1 ACYCLOVIR 200 MG CAPSULE BUPROPION HCL 150 MG TAB ER 24H ACYCLOVIR 200 MG/5ML BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 400 MG TABLET BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 800 MG TABLET BUPROPION HCL

More information

DT Description Price Category Price change Percentage

DT Description Price Category Price change Percentage June 2017 A slight inflationary pressure in most CCGs from mainly Category A increases. Significant price increases: Most of low concern although those involving the less frequently used tamoxifen strengths

More information

MABCAMPATH mg 3 INJ GENZYME BIOPHARMACEUTICALS. MABCAMPBATH mg 3 INJ GENZYME BIOPHARMACEUTICALS

MABCAMPATH mg 3 INJ GENZYME BIOPHARMACEUTICALS. MABCAMPBATH mg 3 INJ GENZYME BIOPHARMACEUTICALS ICON Formulary - November 2016 Class Medicine Name Nappi Strength Form Size Route Manufacturer Abiraterone Acetate ZYTIGA 250 720690001 250 mg 120 ORAL JANSSEN PHARMACEUTICALS Aldesleukin CHIRON IL-2 18

More information

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced Class Medicine Name Nappi Strength Form Size Route Abiraterone Acetate ZYTIGA

More information

NIT165 - RECEIVED PRICE DETAIL. Quantity in Unit/SKU. Company Name. Abbott Healthcare Private Ltd.

NIT165 - RECEIVED PRICE DETAIL. Quantity in Unit/SKU. Company Name. Abbott Healthcare Private Ltd. S C I Total 1 120003 Acenocoumarol/Nicoumalone Tablet 2 mg 10 x 10 15,000 223.33 6 6 26.7996 250.1296 2 120016 Amitriptyle Tab. IP - 25 mg 10X10 4,120 Micron Pharmaceuticals 27.9 12 3.348 31.248 3 120030

More information

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY tlo_seledyn.pdf 1 22.08.2017 14:38:01 C M Y CM MY CY CMY K DOSSIER LIST tlo_seledyn.pdf 1 22.08.2017 14:38:01 PRODUCT NAME PHARMACEUTICAL FORM STRENGTH REFERENCE THERAPEUTIC CLASS ALIMENTARY TRACT & METABOLISM

More information

Product List Finished Dosage Forms (FDF) B2B Business

Product List Finished Dosage Forms (FDF) B2B Business Product List 2017 Finished Dosage Forms (FDF) B2B Business Anaesthetics Dermatology Lidocaine Lidocaine and Prilocaine Dexmedetomidine Hydrochloride Anti-Infectives Amoxicillin Trihydrate and Potassium

More information

PBS Growth. The changing composition of the PBS. PBS Top 10 drugs in transition. Shifting sands for industry as generic volume soars

PBS Growth. The changing composition of the PBS. PBS Top 10 drugs in transition. Shifting sands for industry as generic volume soars PBS Growth The changing composition of the PBS PBS Top 10 drugs in transition Shifting sands for industry as generic volume soars The under co-payment market PBS Update 2014-15 Growth in PBS spending was

More information

PBS PRICE INCREASES - AUGUST 2014 SCHEDULE

PBS PRICE INCREASES - AUGUST 2014 SCHEDULE Price increase review - general PBS benzylpenicillin 600 mg injection, 1 x 600 mg vial 1775K, 3398W, BenPen 3.84 4.38 3486L benzylpenicillin 3 g injection, 1 x 3 g vial 2647H, 3399X, BenPen 6.60 7.55 3487M

More information

Kern Pharma Portfolio 2014

Kern Pharma Portfolio 2014 Kern Pharma Portfolio 2014 DOSSIERS DEVELOPED DURING 2013-2014 ARIPIPRAZOL (ODT) 10mg, 15mg tablets CHONDROITIN SULPHATE 400mg capsules ( well established use ) DEXKETOPROFEN TROMETAMOL 25mg, tablets DULOXETIN

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs ZOLOFT (sertraline hydrochloride) tablets, for oral use This list does not imply that the products on this chart are interchangeable or have the

More information

BULLETIN # 78. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2014

BULLETIN # 78. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2014 BULLETIN # 78 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on July 17, 2014 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

Iraq NDI Iraq 04-J India 05-AH France Famar Lyon France 05-D UNITED ARAB EMIRATES. Iraqi Biocon Limited Indian 06-AA0-001

Iraq NDI Iraq 04-J India 05-AH France Famar Lyon France 05-D UNITED ARAB EMIRATES. Iraqi Biocon Limited Indian 06-AA0-001 nam origmanufacturer nammanufacturer National code Mousel Scientific Iraq NDI Iraq 04-J00-042 Sandoz GmbH Austria for Sandoz GmbH by Sandoz Ilac Sanayi ve India 05-AH0-040 France Famar Lyon France 05-D00-024

More information

MINISTRY OF INDUSTRY AND TRADE OF THE RUSSIAN FEDERATION No. GMP-00903/18/TR STATEMENT of compliance of manufacturer (foreign manufacturer) of medicin

MINISTRY OF INDUSTRY AND TRADE OF THE RUSSIAN FEDERATION No. GMP-00903/18/TR STATEMENT of compliance of manufacturer (foreign manufacturer) of medicin MINISTRY OF INDUSTRY AND TRADE OF THE RUSSIAN FEDERATION No. GMP-00903/18/TR STATEMENT of compliance of manufacturer (foreign manufacturer) of medicinal products for human use with the requirements of

More information

Drug Schedule For RC 143(A)

Drug Schedule For RC 143(A) DRUGS FOR RESPIRATORY SALBUTAMOL TAB - Each Tab to SYSTEM 1 30a contain:salbutamol 2mg. 1 tab 9600000 100000 200000 SALBUTAMOL TAB - Each Tab to 2 30b contain:salbutamol 4 mg. 1 tab 8000000 80000 160000

More information

Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada,

Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada, 1 Appendix Commentary 515 Appendix: Assessing Canada s Drug Shortage Problem Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada, 2013 16 Drug Name Dosage Therapeutic

More information

NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order,

NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, What s New 12.06.2018 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, 2013 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations

More information

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin Clopidogrel Tablet

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin Clopidogrel Tablet (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical

More information

Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories

Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories PAGE 1 OF 7 Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, New Categories A Maximum Reimbursable Price (MRP) or Pharmacare Reimbursement Price (PRP) has been established for

More information

TLS HEALTH Product list up-dated 2017 (Origin: Portugal)

TLS HEALTH Product list up-dated 2017 (Origin: Portugal) TLS HEALTH Product list up-dated 2017 (Origin: Portugal) 1 Alendronic acid 70 mg tablet 4 units 2 Amlodipine 10 mg tablet 20,60 units 3 Amlodipine 5 mg tablet 20,60 units 5 Aripiprazole 10 mg tablet 14,

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 01.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S TYCHE INDUSTRIES LTD., ANDHRA PRADESH, INDIA IMPORT S. NAME OF APPLICANT DIARY TYPE OF 1. PIRAMAL ENTERPRISES LTD. 25471 APPROVAL

More information

Updates to the Alberta Drug Benefit List. Effective November 1, 2018

Updates to the Alberta Drug Benefit List. Effective November 1, 2018 Updates to the Alberta Drug Benefit List Effective November 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

ANNOUNCEMENT. Dear Valued Customer:

ANNOUNCEMENT. Dear Valued Customer: ANNOUNCEMENT Dear Valued Customer: This is to notify you that Ranbaxy Canada s products will not be currently distributed to you through Kohl and Frisch; however Kohl and Frisch will continue their support

More information

Senate Community Affairs Committee ANSWERS TO ESTIMATES QUESTIONS ON NOTICE HEALTH PORTFOLIO

Senate Community Affairs Committee ANSWERS TO ESTIMATES QUESTIONS ON NOTICE HEALTH PORTFOLIO Senate Community Affairs Committee ANSWERS TO ESTIMATES QUESTIONS ON NOTICE HEALTH PORTFOLIO Supplementary Budget Estimates 2018-2019, 24 October 2018 Ref No: SQ18-001266 OUTCOME: 4 - Individual Health

More information

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY tlo_seledyn.pdf 1 22.08.2017 14:38:01 C M Y CM MY CY CMY K DOSSIER LIST AVAILABLE DOSSIERS THERAPEUTIC CLASS / MAIN INDICATION LACTOSE FREE ZONE IV CPP FEASIBILITY ALIMENTARY TRACT & METABOLISM 1. Esomeprazole

More information

6 Each Film coated Tablet Contains :- Ofloxacin 200 mg 10 x 10 Alu

6 Each Film coated Tablet Contains :- Ofloxacin 200 mg 10 x 10 Alu PRODUCT MANUFACTURING LIST Tablet SECTIONS :- S.No. Composition Claim Pack Size Packing Type Remarks 1 Each Film coated Tablet Contains :- Ofloxacin 200 mg 10 x 10 Alu 2 Each Film coated Tablet Contains

More information

BULLETIN # 84. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 22, 2015

BULLETIN # 84. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 22, 2015 BULLETIN # 84 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 22, 2015 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 May 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 May 2014 30 May 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October

More information

TABLETS & CAPSULES. 8 Artemether + Lumafentarine Tablet (24 Tablet ) and Candesartan Tablet 8mg,16mg and 32 mg

TABLETS & CAPSULES. 8 Artemether + Lumafentarine Tablet (24 Tablet ) and Candesartan Tablet 8mg,16mg and 32 mg TABLETS & CAPSULES Sr. No. Name of the product Strength 1 6-Mercaptopurine Tablets 50mg 2 Acetazolamide Tablet 250 mg 3 Al2O3 + Mg(OH)2 chewable Tablet 200 mg/200 mg 4 Allopurinol Tablet 100 mg 5 Ambroxol

More information

Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019

Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019 This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 15 th February 2019 Product

More information

BULLETIN # 79. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 16, 2014

BULLETIN # 79. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 16, 2014 BULLETIN # 79 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 16, 2014 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

New/Revised Product Name Section Changed

New/Revised Product Name Section Changed New/Revised Product Name Section Changed New Abisart New Agiolax New Apo-Ramipril Capsules New Calogen Extra New Candesartan HCTZ-GA New Candesartan-GA New Chemmart Metformin XR New Cholesterol Module

More information

PROFESSIONAL INFORMATION

PROFESSIONAL INFORMATION This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. SCHEDULING STATUS: Unscheduled (Complementary medicine) PROPRIETARY NAME AND DOSAGE FORM: BEROCCA

More information

2018 Step Therapy Criteria

2018 Step Therapy Criteria 2018 Step Therapy Criteria ANGIOTENSIN RECEPTOR BLOCKERS... 2 ANTIDEPRESSANTS... 3 ANTIDEPRESSANTS, MISCELLANEOUS... 4 ANTIDEPRESSANTS, OTHER... 5 ANTIDIABETIC AGENTS... 6 ANTIGOUT AGENTS... 7 ANTIHYPERTENSIVE

More information

NBPDP Formulary Update

NBPDP Formulary Update Bulletin # 830 April 4, 2012 NBPDP Formulary Update Please find attached lists of interchangeable product additions to the New Brunswick Prescription Drug Program Formulary and non-listed products subject

More information

Product List. SL Product Name Generic Name Strength and Dosage form Pack Size

Product List. SL Product Name Generic Name Strength and Dosage form Pack Size 1 Alverin 60 Tab 30's Alverine Citrate 60 mg Tablet 3 x 10's 2 Ancotil 3 Tab 50's Bromazepam 3 mg Tablet 5 x 10's 3 Antif 250 Cap 100's Amoxicillin 250 mg Capsule 10 x 10's 4 Antif 500 Cap 50's Amoxicillin

More information

Tablets, Capsules, Syrup, Dry syrup, Suspensions, Lotions and food products.

Tablets, Capsules, Syrup, Dry syrup, Suspensions, Lotions and food products. Renewed Life sciences - A WHO-GMP Complaint plant situated in pollution free atmosphere and lush green environment of Haridwar, Uttrakhand, Incorporated to pursue an ambitious goal of producing specialized

More information

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017 Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

Medibios Laboratories Private Limited, India Nutraceutical / OTC & Cosmetics product List Product Description

Medibios Laboratories Private Limited, India Nutraceutical / OTC & Cosmetics product List Product Description Sr. No. Medibios Laboratories Private Limited, India Product Description 1 Calcium with Vitamin D3 and Mineral Tablets Each film-coated tablet contains: Calcium Carbonate BP equivalent to Elemental Calcium

More information

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and 5 Infections To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and Southend University Hospital, Antibiotic Guidelines Index 5.1 Antibacterial drugs

More information

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic

More information

Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013

Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Sl. No. F.No. Name of the Company/ Formulation Date of receipt of application

More information

ATYPICAL ANTIPSYCHOTICS

ATYPICAL ANTIPSYCHOTICS Step Therapy CareOregon 2018 Last Updated: 07/27/2018 ATYPICAL ANTIPSYCHOTICS Fanapt Fanapt Titration Pack Paliperidone Er Vraylar The following criteria applies to members who newly start on the drug:

More information

UPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS:

UPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS: 1 1 0.3 Sodium Chloride with 5% Dextrose in 1000 ml in plastic bottle 2 0.3 Sodium Chloride With 5% Dextrose In 500 ml In Plastic Bottle 3 0.9 Sodium Chloride with 5% Dextrose 1000 ml in plastic bottle

More information

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets

More information

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009 2018 PDP Premier Step Therapy Document September 2018 Aggrenox Y0114_18_33144_I_009 aspirin 25 mg-dipyridamole 200 mg capsule,ext.release 12 hr multiphase drug may be given. Step 1 Drug(s): clopidigrel.

More information

Medicines Procurement South West

Medicines Procurement South West MHRA Marketing Authorisations January 2010 to October 2016 Medicines Procurement South West Note: This document is intended to support Trusts with local horizon scanning and supply chain management. The

More information

PROFESSIONAL INFORMATION

PROFESSIONAL INFORMATION This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. SCHEDULING STATUS: Unscheduled: Complementary Medicine PROPRIETARY NAME AND DOSAGE FORM: BEROCCA

More information

PRODUCT LIST GENERAL - TABLETS

PRODUCT LIST GENERAL - TABLETS SR. NO. PRODUCT LIST GENERAL - TABLETS 1 Ciprofloxacin Tablets IP 500 mg 2 Ciprofloxacin And Tinidazole Tablets 3 Cefpodoxime Proxetil Tablets IP 4 Cefixime Dispersible Tablets 200 mg 5 Cefixime Dispersible

More information

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication. ADHD STIMULANTS ATOMOXETINE HCL, DEXEDRINE 10 MG TABLET, DEXEDRINE 5 MG TABLET, DEXMETHYLPHENIDATE HCL, DEXMETHYLPHENIDATE HCL ER, DEXTROAMPHETAMINE 10 MG TAB, DEXTROAMPHETAMINE 5 MG TAB, DEXTROAMPHETAMINE

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have

More information

Aurobindo Pharma Ltd. et al.; Withdrawal of Approval of Eighty-Six Abbreviated New Drug

Aurobindo Pharma Ltd. et al.; Withdrawal of Approval of Eighty-Six Abbreviated New Drug This document is scheduled to be published in the Federal Register on 06/19/2014 and available online at http://federalregister.gov/a/2014-14288, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

US pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health

US pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health US pharmaceutical market: trends, issues, forecast Doug Long Vice President Industry Relations IMS Health 2006 Strategic management review The World Pharmaceutical Market All reproduction rights, quotations,

More information

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017 Drug Category Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Riesbeck's Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml 2160ml Hydroxyzine

More information

Rajasthan Medical Services Corporation Limited, Jaipur

Rajasthan Medical Services Corporation Limited, Jaipur Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV

More information

Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019

Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019 This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 26 th February 2019 Product

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or

More information

20:00. Blood Formulation, Coagulation and Thrombosis. 20:00 Blood Formulation, Coagulation and Thrombosis

20:00. Blood Formulation, Coagulation and Thrombosis. 20:00 Blood Formulation, Coagulation and Thrombosis Blood Formulation, Coagulation and Thrombosis Blood Formulation, Coagulation and Thrombosis 20:04.04 ANTIANEMIA DRUGS (IRON PREPARATIONS) IRON DEXTRAN COMPLEX 50 MG / ML INJECTION 00002205963 DEXIRON LPI

More information

Multi-Vitamin PART OF YOUR ESSENTIALS PACK

Multi-Vitamin PART OF YOUR ESSENTIALS PACK Supplement Details Multi-Vitamin PART OF YOUR ESSENTIALS PACK A perfectly balanced all rounder. Our high quality multivitamin gives you a well balanced daily dose of a plethora of essential vitamins and

More information

List of Liquid Oral/Dry Syrup Section

List of Liquid Oral/Dry Syrup Section List of Liquid Oral/Dry Syrup Section Antibiotics & Anti-Infective S.No Product Name Composition 1. Amoxicillin Oral Suspension BP ( /5ml ) ( Zeemox Syrup ) 2. Amoxicillin Oral Suspension BP (/5ml ) 3.

More information

Approved L1 rates and tenderers for 162 Speciality drugs for the year

Approved L1 rates and tenderers for 162 Speciality drugs for the year Approved L1 rates and tenderers for 162 Speciality drugs for the year 2011-2012 Sl. Name of the 1 G3 2 G6 3 G8 Aceclofenac Tab. - Acyclovir Inj., USP - Adefovir Dipivoxil Tab. - 10mg 10 X 10 4899800 Vial

More information

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of s National Pricing Authority ORDER New

More information

Zylap, Zylap ODT Revised Acimax Tablets Interactions with other medicines, Adverse Reactions Revised Agrippal Contraindications, Adverse

Zylap, Zylap ODT Revised Acimax Tablets Interactions with other medicines, Adverse Reactions Revised Agrippal Contraindications, Adverse /Revised Product Name Section Changed Amlodipine Pfizer Anastrozole Synthon Anastrozole-GA APO-AMISULPRIDE TABLETS Benlysta Beprol Calcitriol-PS Chemmart Anastrozole Escitalopram-GA Femolet Frusemide-PS

More information